Dec, 2016
     AOP Orphan and PharmaEssentia
     announce pivotal ... more

Dec, 2016
     ASH 2016 Information ... more

Nov, 2016
     PharmaEssentia Announces Phase III
     PROUD-PV ... more

Nov, 2016
     475 Final Results from PROUD-PV a
     Randomized Controlled ... more

Jul, 2016
     PharmaEssentia’s Initial Public
     Offering to Fund ... more

ASH 2016 Information
Company Profile
PharmaEssentia Corporation is a global pharmaceutical company founded by a group… more
What is MPD
Meloproliferative diseases (MPD) includes chronic myeloid leukemia (CML)… more
In the field of protein drug design, the process of so-called 'PEGylaltion' of the therapeutic protein… more

Copyright © 2008 PharmaEssentia Corporation All Rights Reserved.